BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16596497)

  • 1. [Percutaneous closure of patent foramen ovale--For].
    Schieffer B
    Dtsch Med Wochenschr; 2006 Apr; 131(14):770. PubMed ID: 16596497
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous transcatheter closure of patent foramen ovale.
    Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
    Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive closure of patent foramen ovale through port-access surgery.
    Spreafico P; Rinaldi M; Alloni A; Perrotta S; Grasselli F; ViganĂ² M
    Neurol Sci; 2003 May; 24 Suppl 1():S20-2. PubMed ID: 12774206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous closure of patent foramen ovale: pathophysiology, indications, and technique.
    Danzi GB; Sesana M; Capuano C; Baglini R
    Neurol Sci; 2003 May; 24 Suppl 1():S17-9. PubMed ID: 12774205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous closure of patent foramen ovale: preliminary experience with the PFO Star].
    Stauffer JC; Serra M; Juillard JM; Seydoux C; Perret F; Owlya R; Savcic M; Beuret P; Goy JJ
    Arch Mal Coeur Vaiss; 2004 Jan; 97(1):37-41. PubMed ID: 15002709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-surgical closure of type-II atrial-septal defect and patent foramen ovale].
    Chatterjee T; Aeschbacher BC; Meier B
    Schweiz Med Wochenschr; 1997 Dec; 127(49):2054-60. PubMed ID: 9476306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure.
    Wertman B; Azarbal B; Riedl M; Tobis J
    J Am Coll Cardiol; 2006 Mar; 47(6):1226-7. PubMed ID: 16545656
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous closure of patent foramen ovale is the procedure of choice for paradoxical embolism.
    Cheng TO
    Circulation; 2003 Oct; 108(17):e126. PubMed ID: 14581392
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous closure of a patent foramen ovale via left axillary vein approach with the Amplatzer Cribriform septal occluder.
    Carter LI; Cavendish JJ
    J Interv Cardiol; 2008 Feb; 21(1):28-31. PubMed ID: 18254787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked foreign body reaction and thrombus formation after transcatheter closure of a patent foramen ovale.
    Schuchlenz HW; Mannweiler S; Martin D
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):591-2. PubMed ID: 16077445
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous patent foramen ovale/atrial septal defect closure: just because we can?
    Opotowsky AR; Webb GD
    Ann Thorac Surg; 2009 Oct; 88(4):1386; author reply 1386-7. PubMed ID: 19766861
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous closure of patent foramen ovale and atrial septal defect.
    Bhindi R; Ormerod OJ
    JAMA; 2008 May; 299(19):2272; author reply 2272-3. PubMed ID: 18492964
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous patent foramen ovale closure.
    Carroll JD; Dodge S; Groves BM
    Cardiol Clin; 2005 Feb; 23(1):13-33. PubMed ID: 15676265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late cardiac perforation after transcatheter closure of patent foramen ovale.
    Cecconi M; Quarti A; Bianchini F; Bucari S; Costantini C; Giovagnoni A; Perna GP
    Ann Thorac Surg; 2006 Jun; 81(6):e29-30. PubMed ID: 16731110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-chest device closure for the minimally invasive management of atrial septal defect in young children.
    Zhang H; Li SJ; Li YQ; Wang H; Hu SS
    Heart Surg Forum; 2007; 10(2):E125-8. PubMed ID: 17597035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    JAMA; 2008 Feb; 299(5):521-2. PubMed ID: 18252881
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac function after percutaneous closure of patent foramen ovale.
    Rao PS; Lorch S
    J Invasive Cardiol; 2007 Jun; 19(6):255-6. PubMed ID: 17541125
    [No Abstract]   [Full Text] [Related]  

  • 19. The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization?
    Karamlou T; Diggs BS; Ungerleider RM; McCrindle BW; Welke KF
    Ann Thorac Surg; 2008 Nov; 86(5):1584-90; discussion 1590-1. PubMed ID: 19049754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure.
    Marie Valente A; Rhodes JF
    Am Heart J; 2007 Apr; 153(4 Suppl):81-4. PubMed ID: 17394907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.